Skip to main content
. 2006 Oct 4;80(24):12017–12024. doi: 10.1128/JVI.01435-06

FIG. 7.

FIG. 7.

VP1u accessibility in baculovirus-derived B19 capsids before (37°C) and after treatment of capsids at 60°C for 3 min. (A) Immunoprecipitation of baculovirus-expressed B19 capsids (Bac-B19) by MAb 1418-1 (VP1u) and MAb 860-55D (Caps). (B) PLA2 activity of native and baculovirus-derived B19 capsids (1.8 and 3.5 μg, respectively).